Clinical trial

Evaluation of RC28-E Injection in Diabetic Retinopathy

NCT04782128

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-05-25

PhasePHASE2

Study timeline

Study start (actual)2021-05-25Date precision: day

Registry last updated2023-10-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyunresolved

Interventions

RC28-E injectionBIOLOGICAL

Sponsors & collaborators

RemeGen Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04782128 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.